Ref. |
Accumulation/ Efflux Model |
Rho 123 Detection |
Study Aim |
Results |
[97] |
LS-180
(48-well plate) |
Fluorometry |
Investigate 7 drugs according to their potencies to up-regulate P-gp activity. |
Verapamil enhanced Rho 123 accumulation factor.
P-gp activity increased after 48 h of pre-treatment with each test compound. |
[98] |
MCF-7/ADR
(24-well plate) |
Fluorometry |
Investigate the effect of quercetin on P-gp. |
Intracellular accumulation of Rho 123 is:
4-fold higher in MCF-7 than in MCF-7/ADR;
2-fold higher in MCF-7/ADR cells pre-incubated with quercetin (10 µM, 24h. |
[99] |
KB-V1 |
Flow Cytometry |
Investigate whether Kuguacin J from Momordica charantia leaves modules P-gp. |
Kuguacin J increased Rho 123 accumulation factor more than 2.5-fold. |
[100] |
L5178-MDR1 |
Flow Cytometry |
Investigate whether TBN is a P-gp modulator. |
Accumulation factor of Rho 123 increased:
10-fold in presence of verapamil; 100-fold in presence of TBN. |
[101] |
PBMEC
(96-well plate) |
Fluorometry |
Examine P-gp functionality in the immortalized PBMEC/C1-2 cell line. |
Verapamil enhance uptake of Rho 123 in PBMEC/C1-2;
After knock-down P-gp, Rho 123 uptake increased. |
[102] |
Caco-2 |
Flow Cytometry |
Investigate in vitro the effect of duloxetine (10µM) on P-gp function. |
Accumulation factor of Rho 123 increased 130% in presence of duloxetine. |
[103] |
Caco-2
(96-well plate) |
Flow Cytometry |
Investigate whether the piperidine alkaloid, lobeline, could inhibit P-gp and reverse P-gp dependent resistance. |
Rho 123 fluorescence in Caco-2 cells is positively correlated with increase of lobeline concentrations. |
[104] |
LLC-PK1
& L-MDR1 |
Flow Cytometry |
Investigate the effect of 7 antipsychotic drugs on P-gp activity in LLC-PK1 and L-MDR1 cells using Rho 123 as P-gp probe. |
Intracellular fluorescence of Rho 123 was 3.1-fold lower in L-MDR1.
PSC833 enhanced the accumulation factor of Rho 123 in L-MDR1.
Antipsychotic drugs decreased Rho 123 accumulation factor in L-MDR1. |
Ref. |
Bi-directional Transport |
Rho 123 Detection |
Study Aim |
Results |
[105] |
HBMEC
& Caco-2 |
Fluorometry |
Investigate whether venlafaxine and desvenlafaxine are inducers of P-gp. |
Venlafaxin (1-50 µM) reduced Papp (A-B) of Rho 123 across HBMEC and Caco-2 by respectively 30% and 25%.
Desvenlafaxin (1-50 µM) had no effect on Rho 123 transport. |
[75] |
Rat intestine membrane in Ussing Chamber |
Fluorometry |
Investigate the potential of a novel polymer (Thiolated PEG-PEI) to inhibit P-gp by evaluating their influence on transport of Rho 123. |
Papp (A-B) of Rho123 enhanced:
2-fold after verapamil addition (100 µM);
3.3-fold after thiolated polymer addition (0.5%, w/v).
R(B-A/A-B) of Rho 123 was reduced to 1.0, 1.4 and 2.0 after thiolated PEG-PEI applied at 0.1%, 0.25% and 0. 5% (w/v). |
[106] |
Rat gastro-intestinal segments in Ussing Chamber |
Spectro-fluorimetry |
Investigate the influence of distinct pharmaceutical excipients on melatonin absorption. Rho 123 was used as positive control. |
Transport of Rho 123 in:
A-B direction: 1052.3±192.6 pg/mL; B-A direction: 3126.5±319.2 pg/mL
Melatonin transport in A-B direction was higher than that of Rho 123 and similar to that in B-A direction. |
[107] |
Caco-2
(12-well plate) |
Fluorometry |
Understand the transport profiles of astilbin and taxifolin in Caco-2 cell model and their effect on P-gp. |
R(B-A/A-B) of Rho 123 ≈ 4.62;
After addition of astilbin or taxifolin (10-1000 µM):
R(B-A/A-B) varied from 4.29 to 4.88
After verapamil addition (100µM): R(B-A/A-B) ≈ 1.22
After pre-incubation with astilbin or taxifolin (1-100 µM) for 24 or 36 h: transport of Rho 123 in B-A direction increased significantly (p<0.05) |
[108] |
hCMEC/D3
(12-well plate) |
Fluorometry |
Examine P-gp function in hCMEC/D3 cells to determine their suitability as in vitro human BBB model for identifying P-gp. |
Papp (A-B) of Rho123 enhanced:
67% by tariquidar (300 nM) and 55% by vinblastine (22 µM).
Papp (B-A) of Rho 123 was not altered. |
[109] |
Rat small intestine everted sac |
HPLC-FL |
Investigate the effect of docosahexaenoic acid (DHA) on intestinal P-gp using Rho 123 as P-gp substrate. |
Transport of Rho 123 in A-B direction:
increased from 4.34±0.69 to 74.83±21.7 pmol/min/6cm with PSC833;
maintained in presence of DHA at concentration range (10-1000 µM). |
[110] |
Rat small intestine everted sac |
Spectro-fluorimetry
HPLC-FL |
Investigate the effects of 50% ethyl acetate extracts of GFJ and OJ on the transport activity of P-gp in rat small intestine. |
Verapamil at 300 µM (p<0.01) increased Rho 123 efflux.
GFJ (p<0.05) and OJ (p<0.05) decreased Rho 123 efflux. |
Ref. |
In vivo animal model |
Rho 123 Detection |
Study Aim |
Effects on pharmacokinetics of Rho 123 |
[83] |
Male Wistar Rats |
Fluorometry |
Investigate the effect of cyclosporin A on nifedipine efflux and pharmacokinetic characteristics. Rho 123 was used as positive control. |
Pre-treated rats with cyclosporin A were administered with Rho123 (0.2 mg/Kg/mL, IV). In comparison to untreated animals, Rho 123 presented:
t1/2 decreased by 19.2%; Cmax increased by 64.7%; AUC0-t increased by 26.5%; CLT decreased by 24.6%
Results for nifedipine were comparable to those from Rho 123. |
[74] |
Male Sprague- Dawley Rats |
Fluorometry |
Provide a proof-of-principle for a delivery system based on thiolated chitosan in vivo in rats. |
AUC0-12 increased 217% by the delivery system based on thiolated chitosan. |